Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanostructural changes in bone quality in a mouse model of chronic kidney disease and treatment with calcitonin.

Bone reports·2025
Same author

CAMKK2 is upregulated in primary human osteoarthritis and its inhibition protects against chondrocyte apoptosis.

Osteoarthritis and cartilage·2023
Same author

Bone quality in an ovariectomized monkey animal model treated with two doses of teriparatide for either 18 months, or 12 months followed by withdrawal for 6 months.

Bone·2022
Same author

Systemic inhibition or global deletion of CaMKK2 protects against post-traumatic osteoarthritis.

Osteoarthritis and cartilage·2021
Same author

Extracellular matrix compression temporally regulates microvascular angiogenesis.

Science advances·2020
Same author

The contribution of global aviation to anthropogenic climate forcing for 2000 to 2018.

Atmospheric environment (Oxford, England : 1994)·2020

Related Experiment Video

Updated: May 25, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
08:53

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

Three years of alendronate treatment does not continue to decrease microstructural stresses and strains associated

J O Green1, T Diab, M R Allen

  • 1Parker H. Petit Institute for Bioengineering and Bioscience and George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, 315 Ferst Drive, Atlanta, GA 30332-0405, USA.

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
|January 13, 2012
PubMed
Summary

Prolonged alendronate treatment did not further decrease trabecular stresses linked to microdamage. Increased mineralization in damaged bone may explain why stresses did not continue to decline with longer alendronate use.

More Related Videos

Proper Positioning and Restraint of a Rat Hind Limb for Focused High Resolution Imaging of Bone Micro-architecture Using In Vivo Micro-computed Tomography
04:24

Proper Positioning and Restraint of a Rat Hind Limb for Focused High Resolution Imaging of Bone Micro-architecture Using In Vivo Micro-computed Tomography

Published on: November 22, 2017

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
04:19

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device

Published on: November 8, 2024

Related Experiment Videos

Last Updated: May 25, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
08:53

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

Proper Positioning and Restraint of a Rat Hind Limb for Focused High Resolution Imaging of Bone Micro-architecture Using In Vivo Micro-computed Tomography
04:24

Proper Positioning and Restraint of a Rat Hind Limb for Focused High Resolution Imaging of Bone Micro-architecture Using In Vivo Micro-computed Tomography

Published on: November 22, 2017

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
04:19

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device

Published on: November 8, 2024

Area of Science:

  • Biomedical Engineering
  • Orthopedics
  • Pharmacology

Background:

  • Alendronate is an anti-remodeling drug reducing osteoporotic fractures.
  • Studies show increased microdamage density with alendronate.
  • Previous research indicated decreased microstructural stresses after 1 year of alendronate.

Purpose of the Study:

  • To investigate the effects of 3-year alendronate treatment on trabecular stresses and strains.
  • To determine if stresses associated with microdamage continue to decrease with extended treatment duration.

Main Methods:

  • Image-based finite element modeling (FEM) was used to analyze stresses and strains in microdamaged trabeculae.
  • Trabeculae from groups treated with different alendronate doses or saline control were compared.
  • 3D microcomputed tomography analyzed architectural characteristics and mineralization.

Main Results:

  • Severely damaged trabeculae in the low-dose alendronate group showed increased stress compared to the high-dose group (p=0.006) and approached significance versus controls (p=0.02).
  • Trabecular mineralization was significantly greater in severely damaged areas of the low-dose group compared to high-dose and control groups.
  • These findings suggest tissue-level changes, specifically mineralization, influence stress distribution.

Conclusions:

  • Trabecular stresses associated with microdamage do not decrease further with prolonged alendronate treatment.
  • Increased mineralization in bone tissue may be responsible for the observed stress patterns.
  • Findings highlight the complex interplay between drug treatment, bone structure, and microdamage accumulation.